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Abstract
Homologous recombination and chromosome segregation in meiosis rely on the timely expression of two splice
variants of the endonuclease SPO11, named α and β, which respectively skip or include exon 2. However, in spite of its
physiological importance, the mechanism underlying Spo11 alternative splicing in meiosis is still unknown. By
screening the activity of factors that are predicted to bind the alternatively spliced region of Spo11, we identified
hnRNPH as a key regulator of SPO11α splicing in mouse spermatocytes. Although hnRNPH was not upregulated in
meiosis concomitantly with the switch in splicing, its recruitment to Spo11 pre-mRNA was favored by selective
modulation of RNA polymerase II (RNAPII) phosphorylation and processivity in proximity of exon 2. The hnRNPH
binding sites were localized near those of splicing factors that promote SPO11β splicing, suggesting that hnRNPH
favors exon 2 skipping by competing out positive regulators. Indeed, hnRNPH binds proximal to a consensus motif for
Sam68, a positive regulator of SPO11β splicing in vitro and in vivo, and it interferes with Sam68 binding to the Spo11
pre-mRNA. Thus, our work reveals that modulation of RNAPII dynamics in concert with hnRNPH recruitment exerts a
combinatorial control of the timely regulated Spo11 splicing during meiosis.
Introduction
Alternative splicing (AS) of pre-mRNAs is a powerful
combinatorial mechanism that allows production of pro-
tein isoforms with different functions from each gene1,2.
AS modularity allows expansion of the coding potential of
the genome and promotes plasticity in its utilization1.
Splicing reactions are orchestrated by a ribonucleoprotein
complex called “spliceosome”, which recognizes
exon–intron junctions, excises introns and ligates exons3.
The lack of stringent consensus sequences at splice
junctions in higher eukaryotes allows flexibility in their
recognition. Numerous RNA-binding proteins (RBPs) act
as splicing factors by interacting with the spliceosome,
and reinforce or weaken recognition of exon–intron
junctions. The interplay between these antagonistic spli-
cing factors determines the choice of regulated exons by
the spliceosome and causes heterogeneity in pre-mRNA
processing1,3,4. In addition, AS is modulated by the rate of
transcription and by epigenetic marks that decorate exons
subject to regulation5,6. As a consequence, changes in the
expression and/or in the activity of any of the factors
contributing to these processes can selectively influence
AS regulation. In particular, the elongation rate of the
RNA polymerase II (RNAPII) is a key factor in co-
transcriptional selection of regulated exons. A fast elon-
gation rate makes more splice sites concomitantly avail-
able within a pre-mRNA, allowing competition between
them and generally favoring stronger splice sites, whereas
a slow rate of elongation promotes inclusion of weak
exons5,7. However, genome-wide analyses indicated that
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several exons were also preferentially skipped by slowing
down the RNAPII8. Such effect could rely on preferential
recruitment of repressive splicing factors by the slow
polymerase in the proximity of the regulated exon, as
demonstrated for the CFTR gene9. Nevertheless, when
and how such specific coordination is achieved under
physiological situations remains largely unknown.
Testis is the organ displaying the highest abundance of
splice variants10. In particular, meiotic spermatocytes dis-
play exceptional transcriptional and splicing diversity10–12.
AS flexibility is exploited by meiotic cells to produce protein
variants uniquely required for the peculiar processes
involved in germ cell differentiation13,14, but also to dictate
the timing of their expression12. An interesting example in
this sense is offered by the Spo11 gene, encoding the
essential endonuclease that establishes DNA double strand
breaks (DSBs) and initiates homologous recombination in
meiosis15,16. The Spo11 gene encodes for two main protein
isoforms (SPO11α and β) which differ for exon 2 skipping
(α) or inclusion (β). Early meiotic spermatocytes synthesize
primarily SPO11β, whereas SPO11α becomes predominant
in late meiosis17. Notably, the timing of Spo11 AS parallels
that of DSB formation during meiosis, with a first wave in
leptotene/zygotene spermatocytes that affects autosomal
chromosomes and a delayed one that preferentially marks
the sex chromosomes in late pachytene. Transgenic mice
expressing only SPO11β were fully competent in estab-
lishing the first DSB wave, but late foci in sex chromosomes,
which appear in concomitance with SPO11α splicing, were
suppressed, leading to inefficient X–Y pairing and recom-
bination18. Thus, the Spo11 splice variants appear to operate
on distinct subsets of meiotic DSBs that are both essential
for gamete differentiation18. However, in spite of its phy-
siological importance, the mechanism(s) underlying Spo11
AS during meiosis are still unknown.
Herein, we describe a novel mechanism involved in the
regulation of Spo11 AS. We found that hnRNPH strongly
induces SPO11α splicing. Interestingly, hnRNPH was not
upregulated in pachytene spermatocytes when the switch in
splicing choice occurs. However, splicing regulation was
paralleled by a decrease in the RNAPII elongation rate
within the Spo11 transcription, which promoted hnRNPH
recruitment and exon 2 skipping. Mechanistically, hnRNPH
competed for binding and splicing of the Spo11 pre-mRNA
with Sam68, a splicing factor whose ablation causes meiotic
defects19. Thus, our work uncovers a fine-tuned combina-
torial mechanism underlying the timely regulation of Spo11
splicing during meiosis.
Results
HnRNPH is a strong modulator of SPO11α splicing
To determine the timing of Spo11 splicing regulation,
we isolated germ cells from CD1 mice during the first
spermatogenic wave (8–25 postnatal day, P), when fronts
of germ cells almost synchronously enter into specific
differentiation stages20. As observed in another strain17,
SPO11β was the predominant variant expressed at P8 and
P14 (Fig. 1a; Supplementary Fig. S1A), when testis is
mostly populated by mitotic spermatogonia and early
meiotic spermatocytes20, respectively. By contrast,
SPO11α becomes the main variant at P18 and P25 (Fig.
1a; Supplementary Fig. S1A), when the most abundant
cells are meiotic spermatocytes20. Treatment with the
RNAPII inhibitor flavopiridol (FPD) to block transcrip-
tion12 showed no significant changes in the stability of
SPO11α and SPO11β mRNAs at these stages (Fig. 1b–d).
These results suggest that a shift in Spo11 splicing reg-
ulation occurs between P14 and P18.
We accurately staged male germ cells by monitoring
assembly of the synaptonemal complex in chromosome
spreads at P14 and P1821. Pachynema represents the
longest stage of prophase I and early pachytene cells can
be distinguished by the lack of expression of the testis-
specific histone H1t, which becomes detectable in mid-
and late-pachytene cells20. Co-staining of chromosome
spreads for the synaptonemal complex protein SCP3 and
H1t did not reveal major changes in the population of
meiotic spermatocytes between P14 and P18 (Supple-
mentary Fig. S1B). Thus, changes in Spo11 AS do not
reflect a clear transition in meiosis.
Next, we searched for factors that could promote
SPO11α splicing. Analysis of binding sites within exon 2
and flanking intronic regions (100 base pair, bp) using
the SpliceAid2 tool (http://193.206.120.249/
splicing_tissue.html) identified several splicing factors
potentially involved in Spo11 AS in both human and
mouse (Fig. 2a; Supplementary Fig. S2A). To test their
effect on Spo11 splicing, we constructed a minigene
encompassing the genomic region from exon 1 to exon
3 (Fig. 2b). Splicing assays in human HEK293T cells,
which do not express SPO11, indicated that the mini-
gene yields both Spo11 variants with a ratio comparable
to that of P14 testis (Fig. 2c). Analysis of the predicted
factors, as well as of other members of the SR and
hnRNP families and of some tissue-specific splicing
factors, revealed that hnRNPF and H were the strongest
inducers of SPO11α splicing (Fig. 2d, e; Supplementary
Fig. S2B), whereas SRSF1, SRSF3, ETR-3, hnRNPA1/A2,
RBM11, PTBP1/2 elicited a much milder effect. On the
other hand, TRA2α/β, Sam68, SLM2, and hnRNPK
enhanced splicing of SPO11β (Fig. 2d, e; Supplementary
Fig. S2B). To test if differential expression of these
splicing factors could account for the switch between
P14 and P18, we performed Western blot analyses on
germ cell extracts (Fig. 2f; Supplementary Fig. S2C).
Remarkably, none of the tested factors displayed chan-
ges in expression compatible with their effect on Spo11
AS, as most were unchanged between P14 and P18 (i.e.,
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Sam68, hnRNPF/H, and PTBP1) or modulated in
opposite direction with respect to their effect on Spo11
splicing (hnRNPA1, SLM2, and ETR-3). Thus, the
switch in SPO11 isoforms is unlikely due to differential
expression of specific splicing factors during meiosis.
A reduced RNAPII elongation rate promotes splicing
of SPO11α
RNAPII processivity within the transcription unit can
also influence AS regulation7–9,22. Since RNAPII activity is
modulated during male meiosis12,23, we asked whether
Spo11 splicing is sensitive to changes in the RNAPII
elongation rate. First, we measured RNAPII processivity
as the ratio between expression of a distal vs. a proximal
intron24. To avoid issues related to intron stability in
steady state transcript levels, we analyzed pulse-labeled
pre-mRNAs synthesized in vivo in a limited time window
(Fig. 3a). Mice were injected with 5-ethynyl uridine (EU)
and its accumulation in nascent RNAs was monitored by
immunofluorescence analysis. We found that a 2-h time
frame was sufficient to yield efficient labeling of sperma-
tocytes with EU in vivo (Supplementary Fig. 3A). Quan-
titative real-time polymerase chain reaction (qRT-PCR)
analysis of EU-labeled transcripts showed that the
RNAPII elongation rate within Spo11 is strongly reduced
in P18 germ cells (Fig. 3b), concomitantly with exon
2 skipping and expression of SPO11α (Fig. 1a). Moreover,
analysis of other proximal regions (introns 2 and 3) in
Spo11 revealed that while all introns were efficiently
represented in nascent transcripts at P14 (Fig. 3c), intron
expression declined with distance from the transcriptional
start site in P18 spermatocytes (Fig. 3d). These results
suggest that the distal portion of the Spo11 pre-mRNA
accumulates at a slower rate at P18, in line with a reduced
elongation rate of the polymerase. Such reduction was
selective for the Spo11 gene, as RNAPII processivity was
unchanged within another meiotic gene (Sycp1) (Fig. 3b).
Accordingly, by comparing P14 and P18 cell extracts we
did not observe a general reduction in phosphorylation of
RNAPII on Ser-2 (Supplementary Fig. 3B), which corre-
lates with fast elongation rate25. However, chromatin
immunoprecipitation (ChIP) experiments highlighted a
specific reduction of RNAPII phosphorylation in the exon
2 region of Spo11 in P18 testis (Fig. 3e), which likely
corresponds to slower rate and pausing of the polymerase,
as we observed increased occupancy of total RNAPII near
exon 2 (Fig. 3f) and a decline in nascent transcript accu-
mulation downstream of it (Fig. 3d).
Fig. 1 Regulation of Spo11 splice variants expression during mouse spermatogenesis. a RT-PCR analysis of endogenous SPO11 mRNA in total
germ cells extracted from testis at different ages (P) using primers flanking exon 2 that distinguish between the α and β variants. The bar graph
represents densitometric analyses of the assay (SPO11α/SPO11β ratio; mean ± SD; n= 3; *P ≤ 0.05, **P ≤ 0.01, unpaired t test). b Representative RT-
PCR analysis of three experiment of endogenous genes in total germ cells from P14 and P18 mice treated or not with 1 μM Flavopiridol (FPD) for 6 h.
The first row represent Spo11 alternative splicing, the second row represent a portion of the Spo11 pre-mRNA (intron 7–exon 8 region), which is
affected by transcriptional inhibition. The Jun gene was used as control of genes with high turnover whereas the 18S ribosomal RNA was used as
normalizer. c, d Bar graph represents quantitative real-time PCR (qPCR) analysis of the level of SPO11α (c) and SPO11β (d) relative to Spo11 total in
total germ cells from P14 and P18 mice treated or not with 1 μM FPD for 6 h (mean ± SD; n= 3; ns not significant, unpaired t test).
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To test whether a slow RNAPII influences Spo11 AS, we
treated HEK293T cells with 5,6-dichloro-1-β-D-ribofur-
anosylbenzimidazole (DRB) to reduce Ser-2 phosphor-
ylation (Fig. 4a) and the RNAPII elongation rate8. DRB
treatment strongly promoted splicing of SPO11α from the
minigene (Fig. 4a). To confirm that a slow polymerase is
sufficient to induce this splicing switch, we engineered
LNCaP cells to express an α-amanitin-resistant wild-type
RPB1, encoding the large subunit of RNAPII, or the
RPB1-R749H mutant, which reduces the elongation rate
independently of phosphorylation26. The basal splicing
and the response to DRB of LNCaP cells transfected with
Fig. 2 Identification of splicing factors that modulate alternative splicing of the Spo11 gene. a Sequence of mouse (upper) and human (lower)
exon 2 sequence showing the consensus motifs for splicing factors (SpliceAid2; http://193.206.120.249/splicing_tissue.html). Bar height represents the
relative strength of the consensus. b Schematic representation of the minigene encoding the alternatively spliced region of the mouse Spo11 gene
from exon 1 to exon 3, including introns. c Representative RT-PCR analysis of five experiments of HEK293T cells, untransfected, transfected with the
Spo11 minigene or empty vector (pCDNA3) (left panel). The right panel shows the comparison with splicing of the endogenous Spo11 gene in P14
testis. d, e RT-PCR analysis of splicing assay performed in HEK293T cells transfected with the Spo11 minigene and expression vectors for the indicated
splicing factors (d); bar graph represents densitometric analysis of the assay (e; SPO11α/SPO11β ratio; mean ± SD; n ≥ 3; *P ≤ 0.05, **P ≤ 0.01, ***P ≤
0.001 related to mock, unpaired t test). f Western blot analysis of splicing factors in isolated germ cells at different ages. The asterisk indicates a
nonspecific band. Coomassie blue staining of the gel was performed as loading control (see Supplementary Fig. 2C). The blots shown are
representative of three images captured.
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the Spo11 minigene was similar to what observed in
HEK293T cells (Supplementary Fig. 3C, D). Moreover,
expression of RPB1-R749H mimicked the effect of DRB
and promoted SPO11α splicing (Fig. 4b). These results
suggest that changes in the RNAPII elongation rate within
the Spo11 locus modulate AS of exon 2 during meiosis.
Fig. 3 The RNAPII elongation rate within the Spo11 gene is modulated in meiosis. a Workflow used for detection of EU-labeled nascent RNAs.
P14 and P18 mice were treated by intraperitoneal injection of EU (300 μg/g). EU-labeled newly synthesized RNAs were collected from testes 2 h after
injection, biotinilated and captured by streptavidin magnetic beads for analysis. b qPCR analysis of nascent Spo11 and Sycp1 transcripts from P14 and
P18 mouse testis. The graph represents the ratio between distal and proximal intron of EU-labeled RNA. (mean ± SD; n= 3; ∗∗P ≤ 0.01, unpaired t test).
c, d qPCR analysis of different regions of the nascent Spo11 pre-mRNA corresponding in P14 (c) and P18 (d) mouse testis (mean ± SD; n= 3; ∗P ≤ 0.05,
∗∗P ≤ 0.01, ∗∗∗P ≤ 0.001 and ∗∗∗∗P ≤ 0.0001 related to int1, one-way ANOVA, Bonferroni’s multiple comparisons test). e, f ChIP assays of serine 2-
phosphorylated (d) or total (e) RNAPII in the exon 2 region of Spo11 in testicular germ cells at P14 and P18. The bar graph shows qPCR signals
expressed as enrichment relative to IgG (mean ± SD, n= 3; *P ≤ 0.05, unpaired t test).
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A slow RNAPII favors recruitment of hnRNPH and skipping
of exon 2 in Spo11 pre-mRNA
Phosphorylation of the carboxyl-terminal domain of
RNAPII modulates its interaction with splicing factors
during pre-mRNA processing27. As hnRNPH strongly
induced SPO11α splicing, we focused on this factor. First,
we evaluated whether hnRNPH interacts with RNAPII.
Co-immunoprecipitation experiments revealed a weak
interaction of hnRNPH with the polymerase under basal
conditions (Fig. 5a). However, DRB-mediated inhibition
of RNAPII Ser-2 phosphorylation promoted its associa-
tion with hnRNPH (Fig. 5a), without affecting hnRNPH
expression (Supplementary Fig. 4A, B). UV cross-link
immunoprecipitation (CLIP) experiments demonstrated
that direct binding of hnRNPH to the Spo11 pre-mRNA
was also significantly enhanced by DRB treatment
(Fig. 5b), suggesting that hnRNPH association with
RNAPII promotes its recruitment to the target pre-
mRNA. Likewise, CLIP experiments documented that
hnRNPH binding to Spo11 pre-mRNA is increased in vivo
in P18 testes (Fig. 5c), concomitantly with the reduction
of RNAPII processivity (Fig. 3b) and SPO11α splicing
(Fig. 1a).
Next, we asked if expression of hnRNPH is required for
the effect of DRB on Spo11minigene splicing. Knockdown
of hnRNPH, and of its close homolog hnRNPF, reduced
SPO11α splicing under basal conditions. Moreover,
hnRNPF/H silencing almost completely abrogated the
effect of DRB on the promotion of this splice variant (Fig.
5d), indicating that hnRNPH is involved in coupling
RNAPII dynamics with Spo11 splicing regulation.
A slow RNAPII was shown to promote ETR-3 recruit-
ment and exon skipping in the CFTR gene9. Since ETR-3
binding sites are present in the Spo11 alternatively spliced
region (Fig. 2a, Supplementary Fig. 2A) and ETR-3 weakly
promotes SPO11α splicing (Fig. 2d, e), we asked whether
it also acted in coupling RNAPII with Spo11 AS. However,
silencing of ETR-3 did not significantly modify the effect
of DRB on exon 2 splicing and ETR-3 was bound to Spo11
transcript in vivo only at P14 (Supplementary Fig. S4C,
D). These experiments indicate a specific role for
hnRNPH in the regulation of Spo11 AS. Moreover, they
suggest a combinatorial control of this event elicited by
changes in RNAPII dynamics and the specific exon
environment that selectively favor hnRNPH recruitment.
hnRNPH competes with Sam68 for the regulation
of Spo11 AS
HnRNPs often repress splicing by competing with
recruitment of other factors or the spliceosome1,4. To test
Fig. 4 Reduction of the RNAPII elongation rate promotes SPO11α splicing. aWestern blot and RT-PCR analyses of a representative splicing assay
performed in HEK293T cells transfected with the Spo11 minigene and treated with DRB (25 μg/ml) for 16 h. The bar graph represents densitometric
analyses of the SPO11α/SPO11β ratio (mean ± SD, n= 3; *P ≤ 0.05, unpaired t test). The Western blot analysis shows the levels of serine 2-
phosphorylated RNAPII in the HEK293T cells used for the assay. b Western blot and RT-PCR analysis of a representative Spo11 minigene splicing assay
performed in LNCaP cells stably infected with the lentiviral vector pLV-Rbp1-WT-Amr or pLV-Rbp1-R749H-Amr and treated with 2 μg/ml of α-amanitin
for 48 h, when endogenous RNAPII was inactive (mean ± SD, n= 3; ∗∗∗P ≤ 0.001, unpaired t test). The Western blot analysis shows the similar levels of
expression of recombinant wild-type and mutant RNAPII in the infected LNCaP cells used for the experiment. The noninfected cells show absence of
endogenous RNAPII after treatment with α-amanitin for 48 h. The blots shown are representative of three images captured (a, b).
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whether occupancy of regulatory sequences by hnRNPH
promoted exon skipping by competing out positive reg-
ulators, we focused on Sam68 because its binding site is
located in close proximity to that of hnRNPH (Fig. 6a).
Sam68 promotes exon 2 inclusion (Fig. 2d, e) and it
cooperates with the spliceosomal U1snRNP in exon
recognition28,22. Analysis of testes from juvenile Sam68
knockout mice (P10) showed a significant reduction in
Spo11 exon 2 inclusion (Fig. 6b, c), suggesting the phy-
siological relevance of Sam68-mediated regulation. To
test whether hnRNPH competes with Sam68 for Spo11
AS regulation, we performed splicing assays with a
concentration of Sam68 that induced almost complete
splicing of the SPO11β variant and increasing amounts of
hnRNPH. We observed a dose-dependent reversion of
splicing with increasing hnRNPH levels (Fig. 6d, e).
However, even at its highest dose, hnRNPH was unable to
completely switch splicing toward the SPO11α variant in
the presence of Sam68 overexpression.
To test whether hnRNPH competes with Sam68 for
binding to exon 2, we performed CLIP assays in
HEK293T cells transfected with the Spo11 minigene.
Sam68 was efficiently recruited to the Spo11 pre-mRNA
when expressed alone. However, its binding was strongly
Fig. 5 A slow RNAPII favors recruitment of hnRNPF/H in the Spo11 pre-mRNA. a Co-immunoprecipitation analysis performed in HEK293T cells
treated or not with DRB (25 μg/ml). Nuclear extracts were immunoprecipitated with control IgGs or anti-RNAPII antibodies in the absence of RNAse A
and analyzed by Western blot for total and serine 2-phoshporylated RNAPII and hnRNPH. Nucleolin (NCL) was used as loading control for the nuclear
extracts. b CLIP assay of hnRNPH binding to the Spo11 minigene in transfected HEK293T cells treated or not with DRB (25 μg/ml). Cells were UV-cross-
linked and immunoprecipitated with control IgGs or anti-hnRNPH antibody. The Western blot shows specific immunoprecipitation of hnRNPH. The
bar graph shows qPCR signals amplified from the CLIP assays expressed as Spo11 exon 2 enrichment in the anti-hnRNPH immunoprecipitates relative
to control IgGs (mean ± SD; n= 3; ***P ≤ 0.001, unpaired t test). c CLIP assay of hnRNPH binding to the endogenous Spo11 pre-mRNA. P14 and P18
mouse testes were UV-cross-linked and immunoprecipitated with control IgGs or anti-hnRNPH antibody. The Western blot shows specific
immunoprecipitation of hnRNPH. The bar graph shows qPCR signals amplified from the CLIP assays expressed as Spo11 exon 2 enrichment in the
anti-hnRNPH immunoprecipitates relative to control IgGs (mean ± SD; n= 3; ***P ≤ 0.001, unpaired t test). d RT-PCR analysis of Spo11 minigene
splicing assays in HEK293T cells transfected with scramble and hnRNPF/H siRNAs. Silencing efficiency was assessed by Western blot analysis. Bar
graph represents the densitometric analysis of the SPO11α/SPO11β ratio (mean ± SD; n= 3; *P ≤ 0.05, ***P ≤ 0.001, unpaired t test). The blots shown
are representative of three images captured (a–d).
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Fig. 6 hnRNPH competes with Sam68 in the binding of exon 2 of Spo11 pre-mRNA. a Schematic representation of the possible competition
between hnRNPH and dimeric Sam68 for the binding to Spo11 exon 2 near the 5′ splice site. b Representative RT-PCR analysis of endogenous Spo11
mRNA in germ cells extracted from wild-type (wt) or Sam68 knockout (ko) testes. c Bar graph represents the densitometric analysis of the SPO11α/
SPO11β ratio in germ cells extracted from wild-type (wt) or Sam68 knockout (ko) testes (mean ± SD; n= 4; *P ≤ 0.05, unpaired t test). d RT-PCR
analysis of Spo11 minigene splicing assay performed in HEK293T cells transfected with or without Flag-Sam68 or increasing amounts of Flag-hnRNPH.
Relative expression of Sam68 and hnRNPH was detected by Western blot using the anti-FLAG antibody. e Bar graph represents densitometric analysis
of the SPO11α/SPO11β ratio of Spo11 minigene splicing assay performed in HEK293T cells transfected with or without Flag-Sam68 or increasing
amounts of Flag-hnRNPH (mean ± SD; n= 3, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, unpaired t test). f CLIP assays of MYC-Sam68 binding to the Spo11 pre-
mRNA. HEK293T cells were transfected with the Spo11 minigene and Myc-Sam68 or Flag-hnRNPH. Immunoprecipitation of Myc-Sam68 was analyzed
by Western blot with anti-MYC antibody. The bar graph shows qPCR signals of Spo11 exon 2 amplified from the CLIP assays expressed as enrichment
in the anti-MYC-Sam68 immunoprecipitates in Myc-Sam68 expressing cells relative to cells expressing the MYC empty vector (mean ± SD; n= 3;
**p ≤ 0.01, unpaired t test). g CLIP assay of endogenous Sam68 binding to the Spo11 minigene in HEK293T cells transfected with scramble and
hnRNPF/H siRNAs. Silencing efficiency was assessed by Western blot analysis (Supplementary Fig. S5). Cells were immunoprecipitated with control
IgGs or anti-Sam68 antibody. The Western blot shows specific immunoprecipitation of Sam68. The bar graph shows qPCR signals amplified from the
CLIP assays expressed as Spo11 exon 2 enrichment in the anti-Sam68 immunoprecipitates relative to control IgGs (mean ± SD; n= 3; *P ≤ 0.05,
unpaired t test). The blots shown are representative of three images captured (d, f, g).
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reduced when hnRNPH was overexpressed (Fig. 6f). By
contrast, hnRNPF/H knockdown caused a small but sig-
nificant increase in the binding of Sam68 to the Spo11
pre-mRNA (Fig. 6g). These findings suggest that binding
of hnRNPH near specific regulatory regions hinders the
recruitment of Sam68, thus promoting exon 2 skipping
from the Spo11 pre-mRNA.
Discussion
Male germ cells display the highest complexity in gene
expression and AS regulation among mammalian tis-
sues10,12. This extensive utilization of the coding potential
and plasticity of the genome may underlie the unique
features required for germ cell differentiation29. One such
unique feature is the timely appearance in early meiosis of
DSBs driven by SPO1115,16, which allow recombination,
pairing and proper segregation of homologous chromo-
somes30. Notably, the main SPO11 splice variants,
SPO11α and β, are differentially expressed in spermato-
cytes and both are necessary for proper meiosis18.
Nevertheless, how temporal regulation of Spo11 splicing is
achieved is currently unknown. Herein, we have identified
a combinatorial control that insures Spo11 AS regulation
at a specific time in meiosis, which relies on the concerted
action of RNAPII and the splicing factor hnRNPH. A fast
RNAPII elongation rate in early meiosis prevents binding
of hnRNPH to the Spo11 pre-mRNA, whereas the reduced
speed of RNAPII in late meiosis promotes hnRNPH
recruitment and skipping of exon 2 (Fig. 7). These find-
ings uncover a novel modality of developmental regula-
tion of splicing that couples changes in RNAPII dynamics
with specific recruitment of splicing factors during
meiosis, thus guaranteeing accurate control of SPO11
isoform expression in the differentiating gametes.
HnRNPH, and its close homolog hnRNPF, are potent
regulators of exon 2 skipping. Interestingly, in primary
germ cells hnRNPH is differentially recruited in proximity
of the Spo11 exon 2 splice site at P14 and P18, even
though its expression level remains unchanged. However,
we found that recruitment of hnRNPH to Spo11 exon
2 sequences is sensitive to RNAPII dynamics, whose
regulation during meiosis has been documented12,31,32.
Several lines of evidence support this conclusion. First,
interaction of hnRNPH and RNAPII is promoted by Ser-2
dephosphorylation; second, RNAPII phosphorylation in
Ser-2 and RNAPII processivity within the Spo11 locus are
modulated during meiosis; third, decreased processivity
correlates with recruitment of hnRNPH to exon 2 in the
Spo11 pre-mRNA; fourth, ectopic manipulation of RNA-
PII dynamics recapitulates regulation of SPO11α splicing
in an hnRNPH-dependent fashion. These findings suggest
that a fast RNAPII elongation rate prevents binding of
hnRNPF/H to the Spo11 pre-mRNA, allowing its recog-
nition by positive regulators that promote SPO11β
Fig. 7 Model of Spo11 alternative splicing regulation in meiosis. Schematic representation of the combinatorial control of Spo11 alternative
splicing elicited by RNAPII dynamics and hnRNPH or Sam68 recruitment. At P14, the fast elongation rate of RNAPII promotes recruitment of Sam68
and inclusion of exon 2, thus yielding SPO11β. At P18, reduction of the speed of RNAPII favors recruitment of hnRNPH, which competes out Sam68
and promotes exon 2 skipping and SPO11α splicing.
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splicing (Fig. 7). Reduced speed of RNAPII later in
meiosis, instead, favors recruitment of hnRNPH, leading
to displacement of positive regulators and splicing of
SPO11α. This competition-based mechanism is also
supported by the observation that the strongest hnRNPH
binding sites in exon 2 overlap with the consensus motif
for Sam68, which promotes SPO11β splicing. Thus,
occupancy of the region flanking the 5′ splice site by
hnRNPH may prevent recruitment of positive regulators
(i.e., Sam68) that are necessary for efficient exon 2 defi-
nition. Mechanistically, since Sam68 cooperates with
U1snRNP to promote exon recognition in male germ
cells31, binding of hnRNPH to the exon 2–intron 2 region
may disrupt this interaction at P18 and cause the switch in
SPO11 isoforms. Thus, our work suggests that combina-
torial control of RNAPII dynamics and recruitment of
specific splicing factors may dictate temporal regulation of
a splicing pattern during meiosis.
The physiological relevance of most annotated splice var-
iants remains largely unknown. In the case of SPO11,
expression of SPO11β alone was not sufficient to fully
compensate for the ablation of the gene18. SPO11β-only mice
were defective in pairing of the X–Y chromosomes in late
meiosis, suggesting that SPO11α plays a nonredundant role
and physiologically compensates for this defect18. This
observation also indicates that lack of proper SPO11α spli-
cing during meiosis exposes to higher risk of sex chromo-
somes aneuploidy, a pathological condition that gives rise to
human diseases like the Klinefelter syndrome33. Thus, while
changes in Spo11 expression levels can be tolerated to some
extent by homeostatic mechanisms that control crossover
formation34, lack of expression of a splice variant of the gene
yields non rescuable defects. In this scenario, our findings
provide mechanistic insights into the temporal control of
Spo11 splicing during meiosis and point to hnRNPH and
Sam68 as key regulators of this process. Notably, Sam68
knockout spermatocytes undergo apoptosis in late meiosis19.
Thus, our findings also suggest that dysregulation of SPO11α
expression may cause defective homologous recombination
in vivo, resulting in increased meiotic cell death.
Materials and methods
Germ cells isolation and culture
Germ cells were obtained from testes of Swiss CD-1
mice as reported23. Briefly, after testis digestion with
collagenase and trypsin, the cell suspension was plated for
4 h in minimum essential medium (MEM), supplemented
with 1 mM DL-lactic acid, 2 mM sodium pyruvate, 10%
fetal calf serum, to promote adhesion of somatic cells.
Germ cells that remain in suspension were then collected.
For transcription inhibition, following two washes in
MEM, germ cells were released for 6 h in fresh medium
added or not with 1 μM FPD (Sigma-Aldrich) and then
harvested for analysis.
Spo11 minigene construct and PCR analyses
The Spo11 minigene was amplified from genomic DNA
of P14 mouse testis using primers reported in the Sup-
plementary Table, cloned into pCDNA3.1(−) vector, and
validated by sequencing.
For PCR analyses, RNA from samples was extracted
using TRIzol reagent (Invitrogen), digested with RNase-
free DNase (Roche), retrotranscribed (1 μg) using M-MLV
reverse transcriptase (Promega) and used for PCR reac-
tions (GoTaq, Promega). RT-qPCR analyses were per-
formed using LightCycler 480 SYBR Green I Master with
the LightCycler 480 System (Roche). Control reactions
omitted M-MLV reverse transcriptase. Primers are listed
in the Supplementary Table 1.
Cell culture, transfections, and treatment
HEK293T cells were grown in Dulbecco’s modified
Eagle’s medium (Sigma Aldrich), supplemented with 10%
fetal bovine serum (FBS) (Gibco), gentamicin sulfate
(50 g/ml) (Aurogene), 1% nonessential aminoacids
(Euroclone), penicillin (50 U/ml)/streptomycin (50 g/ml)
(Corning). LNCaP cells were grown in RPMI 1640 med-
ium (LONZA), supplemented with 10% FBS (Gibco),
penicillin (50 U/ml)/streptomycin (50 g/ml) (Corning),
gentamicin sulfate (50 g/ml) (Aurogene), 1% nonessential
aminoacids (Euroclone), 10 mM Hepes (Euroclone), and
1mM sodium pyruvate (Aurogene). Transfections were
performed using Lipofectamine 2000 (Invitrogen) and
2 μg of pCDNA3.1-Spo11 minigene with or without
expression vectors for the indicated proteins; 6 h after
transfection, cells were treated or not with 25 μg/ml DRB
for 16 h before harvest. For RNA interference, cells were
transfected with appropriate siRNAs (Sigma-Aldrich)
using Lipofectamine RNAiMAX (Invitrogen) and har-
vested 48 h later for analyses.
Pull-down assay of nascent RNAs
Testis of P14 and P18 mice were collected after 2 h of
intraperitoneal injection of EU (Life Technologies) or PBS
as control, as described12. Samples were collected in
Trizol and RNA was isolated, biotinylated and captured
using the Click-IT Nascent RNA Capture kit (Life Tech-
nologies). Captured nascent RNAs were retrotranscribed
using the SuperScript VILO cDNA Synthesis Kit (Life
Technologies) followed by qPCR analysis.
Cross-link immunoprecipitation (CLIP) experiments
CLIP experiments were performed as described35. Briefly,
HEK293T cells and testicular cells were irradiated on ice
(400mJ/cm2) in PBS, scraped off and centrifuged for 5min
at 300g at 4 °C. After sample processing, extracts (0.5–1mg)
were immunoprecipitated using anti-hnRNPH (provided by
Prof. B. Chabot, Université de Sherbrooke, Canada), anti-
MYC (Santa Cruz Biotechnology) or rabbit IgG (control) in
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the presence of protein G magnetic (Life Technologies).
After stringent washes and Proteinase K treatment (1 h at
55 °C), RNA was isolated by standard procedures, retro-
transcribed with random primers, and M-MLV reverse
transcriptase (Promega) and used for qPCR. RNA asso-
ciated with hnRNPH is represented as fold enrichment
relative to IgG samples, RNA associated with MYC is
represented as fold enrichment relative to empty vector.
ChIP assay
ChIP was performed as described36 using P14 and P18
testes crosslinked in 1% (vol/vol) formaldehyde for 10min
at room temperature and quenched with 125mM glycine
for 5min.
Statistical analysis
Statistical tests were performed by the Student t test or
One-Way ANOVA using GraphPad Prism6; P ≤ 0.05 was
considered significant. No analyses were used to pre-
determine sample size. The experiments were not ran-
domized and investigators were not blinded to allocation
during experiments and outcome assessment.
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